Bio Protocol, a decentralized science-focused network, is expanding to the Solana blockchain, even as its native token experiences a significant market downturn.
The price of BIO has dropped to $0.53, down over 64% from its peak on January 3. In the past 24 hours, the token has fallen over 10%, while trading volume has decreased by 15.4%. Notably, the broader market is also seeing losses, largely due to Bitcoin (BTC) trading below $95,000.
The expansion to Solana is being carried out through a collaboration with Wormhole, a bridge that will facilitate the swapping of BIO tokens between the Ethereum and Solana networks. This integration, which will allow transactions at lower costs, aims to position Bio Protocol as a multichain platform. In addition, the project plans to expand to the Base network, the layer-2 solution developed by Coinbase.
Despite the challenges faced by its token, Bio Protocol is continuing with its growth plan. Currently, the platform hosts eight Bio Decentralized Autonomous Organizations (BioDAOs), including projects such as VitaDAO, focused on aging research, and AthenaDAO, which focuses on women’s health. These initiatives aim to solve health issues through decentralized research and crowdfunding, supported by Bio Launchpad, which has raised over $30 million to fund these projects.
While the decline in Bio Protocol’s token price raises uncertainty about its immediate future, the history of similar projects suggests that recovery could take time. Recent airdrops from Wormhole and Notcoin have resulted in significant losses from their all-time highs, indicating that BIO may follow a similar trajectory.
免責事項:info@kdj.com
提供される情報は取引に関するアドバイスではありません。 kdj.com は、この記事で提供される情報に基づいて行われた投資に対して一切の責任を負いません。暗号通貨は変動性が高いため、十分な調査を行った上で慎重に投資することを強くお勧めします。
このウェブサイトで使用されているコンテンツが著作権を侵害していると思われる場合は、直ちに当社 (info@kdj.com) までご連絡ください。速やかに削除させていただきます。
